HiMedica was founded in December 2001 to offer product design and development, manufacturing capabilities and partnerships with companies looking to sell skin and woundcare products in both the hospital and community and retail over-the-counter markets.

We look to offer our partners generic products that meet current specifications and market requirements, as well as to develop and supply next generation products with unique selling points and new materials technology.

HiMedica seeks partners that are looking for support in defining the niche, the product, the materials specification, obtaining regulatory approval (CE marking, Drug Tarrif, FDA 510K approval/exemption or Medicare Part B HCPCS codes) and launching into the wound and skincare markets.

HiMedica is certified to ISO 13486 for the design and manufacture of woundcare devices. Its notified body is Lloyds Register of Quality Assurance.

Christopher Ives PhD., Managing Director